| 15.11.2023 07:00 | SNG | Grant of Options | RNS |
| 11.10.2023 11:19 | SNG | IN BRIEF: Synairgen names Phytome's Joseph Colliver as CFO | Alliance |
| 11.10.2023 07:00 | SNG | Appointment of New Chief Financial Officer | RNS |
| 03.10.2023 09:59 | SNG | Synairgen promotes Marcin Mankowski to chief medical officer | Alliance |
| 03.10.2023 07:00 | SNG | Appointment of Chief Medical Officer | Reach |
| 21.09.2023 13:48 | SNG | IN BRIEF: Synairgen narrows interim loss on reduced R&D spending | Alliance |
| 21.09.2023 07:00 | SNG | Interim Results | RNS |
| 29.06.2023 18:02 | SNG | Result of AGM | RNS |
| 29.06.2023 10:00 | SNG | Annual General Meeting Presentation | RNS |
| 22.06.2023 15:44 | VRCI, TRR, TXP | UK shareholder meetings calendar - next 7 days | Alliance |
| 22.06.2023 07:00 | SNG | Grant of Options | RNS |
| 23.05.2023 07:00 | SNG | Posting of Annual Report and Notice of AGM | RNS |
| 27.04.2023 14:44 | SNG, CUSN, AC8 | EARNINGS SUMMARY: Synairgen loss narrows; aims to develop SNG001 | Alliance |
| 27.04.2023 07:00 | SNG | 2022 Full Year Results | RNS |
| 20.04.2023 15:41 | WPP, ULVR, SNG | UK earnings, trading statements calendar - next 7 days | Alliance |
| 17.04.2023 07:00 | SNG | Notice of Full Year results | RNS |
| 13.03.2023 16:40 | SNG | Second Price Monitoring Extn | RNS |
| 13.03.2023 16:35 | SNG | Price Monitoring Extension | RNS |
| 03.02.2023 16:40 | SNG | Second Price Monitoring Extn | RNS |
| 03.02.2023 16:35 | SNG | Price Monitoring Extension | RNS |
| 17.01.2023 16:35 | SNG | Price Monitoring Extension | RNS |
| 13.01.2023 16:40 | SNG | Second Price Monitoring Extn | RNS |
| 13.01.2023 16:35 | SNG | Price Monitoring Extension | RNS |
| 23.12.2022 17:05 | DCI, SEEN, SNG | TRADING UPDATES: SulNOx raises funds; Synairgen shares trial results | Alliance |
| 23.12.2022 11:30 | SNG | SPRINTER Trial Results Published | Reach |
| 14.12.2022 16:35 | SNG | Price Monitoring Extension | RNS |
| 01.12.2022 07:00 | SNG | Board Changes | RNS |
| 07.11.2022 16:40 | SNG | Second Price Monitoring Extn | RNS |
| 07.11.2022 16:35 | SNG | Price Monitoring Extension | RNS |
| 03.11.2022 16:40 | SNG | Second Price Monitoring Extn | RNS |
| 03.11.2022 16:35 | SNG | Price Monitoring Extension | RNS |
| 20.10.2022 16:35 | SNG | Price Monitoring Extension | RNS |
| 06.10.2022 13:35 | SNG | Holding(s) in Company | RNS |
| 04.10.2022 10:53 | SNG | Synairgen test results positive but not "statistically significant" | Alliance |
| 04.10.2022 07:02 | SNG | Data from the US NIH-led ACTIV-2 Phase 2 trial | RNS |
| 29.09.2022 20:30 | CCS, VSL, OMI | EARNINGS SUMMARY: Angle revenue up; Synairgen, Bango loss widens | Alliance |
| 29.09.2022 07:01 | SNG | Board Changes | RNS |
| 29.09.2022 07:00 | SNG | Interim Results | RNS |
| 22.09.2022 15:48 | XLM, SNG, PYC | UK earnings, trading statements calendar - next 7 days | Alliance |
| 20.09.2022 07:00 | SNG | SPRINTER Long COVID data presented at IDWeek | RNS |
| 15.09.2022 07:00 | SNG | Notice of Interim Results | RNS |
| 08.09.2022 16:40 | SNG | Second Price Monitoring Extn | RNS |
| 08.09.2022 16:35 | SNG | Price Monitoring Extension | RNS |
| 07.09.2022 10:30 | SNG | IN BRIEF: Synairgen shares rise as positive data found for COPD | Alliance |
| 07.09.2022 07:00 | SNG | Positive Findings from SG015 Tri-al Analysis | RNS |
| 05.09.2022 18:25 | OCI, SNG, BHL | TRADING UPDATES: Bradda wins drilling approval; Oakley invests in vLex | Alliance |
| 05.09.2022 07:00 | SNG | Company Announce Collaboration on UNIVERSAL Trial | Reach |
| 06.07.2022 07:00 | SNG | Grant of Options | RNS |
| 30.06.2022 13:45 | SNG | Result of AGM | RNS |
| 23.06.2022 16:40 | SNG | Second Price Monitoring Extn | RNS |
| 23.06.2022 16:35 | SNG | Price Monitoring Extension | RNS |
| 23.06.2022 16:02 | VAL, TRN, TRP | UK shareholder meetings calendar - next 7 days | Alliance |
| 15.06.2022 14:30 | SNG | Holding(s) in Company | RNS |
| 09.06.2022 15:00 | SNG | Exercise of Options and Total Voting Rights | RNS |
| 06.06.2022 16:25 | SNG | Posting of Annual Report & Notice of AGM | RNS |
| 25.05.2022 12:00 | SNG | IN BRIEF: Synairgen shares fall as loss widens on higher costs | Alliance |
| 25.05.2022 07:00 | SNG | Full Year Results | RNS |
| 18.05.2022 16:36 | SNG | Price Monitoring Extension | RNS |
| 16.05.2022 12:18 | SNG | IN BRIEF: Synairgen shares soar on positive analysis of SNG001 | Alliance |
| 16.05.2022 07:00 | SNG | Synairgen presents at ATS 2022 | RNS |
| 25.04.2022 07:00 | SNG | Presentation at ECCMID | Reach |
| 19.04.2022 16:40 | SNG | Second Price Monitoring Extn | RNS |
| 19.04.2022 16:35 | SNG | Price Monitoring Extension | RNS |
| 06.04.2022 14:10 | SNG | Holding(s) in Company | RNS |
| 05.04.2022 07:00 | SNG | Synairgen to present at ATS 2022 | Reach |
| 17.03.2022 11:48 | SNG | IN BRIEF: Synairgen falls as patient recruitment in US trial halted | Alliance |
| 17.03.2022 11:21 | AUTG, FIPP, SNG | AIM WINNERS & LOSERS: Synairgen sinks 18% after US Covid study halted | Alliance |
| 17.03.2022 07:25 | SNG | Synairgen Provides Update on ACTIV-2 Trial | RNS |
| 14.03.2022 16:41 | SNG | Second Price Monitoring Extn | RNS |
| 14.03.2022 16:36 | SNG | Price Monitoring Extension | RNS |
| 11.03.2022 16:40 | SNG | Second Price Monitoring Extn | RNS |
| 11.03.2022 16:35 | SNG | Price Monitoring Extension | RNS |
| 08.03.2022 16:35 | SNG | Holding(s) in Company | RNS |
| 08.03.2022 15:52 | SNG | Holding(s) in Company | RNS |
| 04.03.2022 13:36 | SNG | Holding(s) in Company | RNS |
